{"DataElement":{"publicId":"3235095","version":"1","preferredName":"Neoplasm Mitotic Count Score Category","preferredDefinition":"Classification or group representing a biospecimen's mitotic activity per ten (10) high power fields.","longName":"NEOP_MIT_CT_SC_CAT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3119280","version":"1","preferredName":"Malignant Neoplasm Mitotic Count Rate","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004_The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields._A measurement of degree, speed, or frequency relative to time. (NCI)","longName":"2186369v1.0:3119278v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3119278","version":"1","preferredName":"Mitotic Count Rate","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.:A measurement of degree, speed, or frequency relative to time. (NCI)","longName":"C47864:C25636","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Count","conceptCode":"C47864","definition":"The number of mitoses identified under the microscope in tumors.  It is one of the parameters that determine the grade of malignant tumors.  The method of counting varies, according to the specific tumor examined.  Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Rate","conceptCode":"C25636","definition":"A measurement of degree, speed, or frequency relative to time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-85C7-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-85D8-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3235091","version":"1","preferredName":"Mitotic Count Score Category","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields._A number or range of numeric values measuring performance, function, quality, or ability._Category; used informally to mean a class of things.","longName":"MIT_CT_SC_CAT","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Score of 3","valueDescription":"Mitotic Count Score of 3","ValueMeaning":{"publicId":"3235092","version":"1","preferredName":"Mitotic Count Score of 3","longName":"3235092","preferredDefinition":"Mitotic Count Score is 17 or more mitoses per 10 high power fields","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3286987-53AA-96C8-E040-BB89AD43475F","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3286987-53C3-96C8-E040-BB89AD43475F","beginDate":"2011-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-13","modifiedBy":"ONEDATA","dateModified":"2011-05-13","deletedIndicator":"No"},{"value":"Score of 2","valueDescription":"Mitotic Count Score of 2","ValueMeaning":{"publicId":"3235093","version":"1","preferredName":"Mitotic Count Score of 2","longName":"3235093","preferredDefinition":"Mitotic Count Score is 9 to 16 mitoses per 10 high power fields.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3286987-53CD-96C8-E040-BB89AD43475F","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3286987-53E6-96C8-E040-BB89AD43475F","beginDate":"2011-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-13","modifiedBy":"ONEDATA","dateModified":"2011-05-13","deletedIndicator":"No"},{"value":"Score of 1","valueDescription":"Mitotic Count Score of 1","ValueMeaning":{"publicId":"3235094","version":"1","preferredName":"Mitotic Count Score of 1","longName":"3235094","preferredDefinition":"Mitotic Count Score is less than or equal to 8 mitoses per 10 high power fields.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3286987-53F0-96C8-E040-BB89AD43475F","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3286987-5409-96C8-E040-BB89AD43475F","beginDate":"2011-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-13","modifiedBy":"ONEDATA","dateModified":"2011-05-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3235090","version":"1","preferredName":"Mitotic Count Score Category","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.:A number or range of numeric values measuring performance, function, quality, or ability.:Category; used informally to mean a class of things.","longName":"C47864:C25338:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Count","conceptCode":"C47864","definition":"The number of mitoses identified under the microscope in tumors.  It is one of the parameters that determine the grade of malignant tumors.  The method of counting varies, according to the specific tumor examined.  Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3286987-5387-96C8-E040-BB89AD43475F","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-13","modifiedBy":"ONEDATA","dateModified":"2011-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP:College of American Pathologists","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3286987-5398-96C8-E040-BB89AD43475F","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-13","modifiedBy":"REEVESD","dateModified":"2011-05-13","changeDescription":"Based on CAP recommendations","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2879403","version":"1","longName":"Virginia Commonwealth University","context":"NCIP"},{"publicId":"2879404","version":"1","longName":"VCU New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Mitotic Count","type":"Preferred Question Text","description":"Mitotic Count","url":null,"context":"NCIP"}],"origin":"CAP:College of American Pathologists","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3286987-544E-96C8-E040-BB89AD43475F","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-05-13","modifiedBy":"REEVESD","dateModified":"2011-05-19","changeDescription":"Curated to support VCU clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}